New kidney replacement therapies with engineering technology
3D bioprinting and stem cell-based tissue engineering facilitate approaches to chronic kidney disease treatments
Stay updated with breaking news from Biologically Inspired Engineering. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
3D bioprinting and stem cell-based tissue engineering facilitate approaches to chronic kidney disease treatments
IQX Limited (NSX:IQX) today announced it has received a worldwide license from Harvard's Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University.
Wyss Institute for Biologically Inspired Engineering at Harvard University, March 07, 2022 (GLOBE NEWSWIRE) -- (BOSTON) — Today, the Wyss Institute for Biologically Inspired Engineering at Harvard University and Australian
Trestle Biotherapeutics is working on building functional kidney tissue that could turn the tide in the treatment of chronic kidney disease.
/PRNewswire/ -- Based on strong interest from the US market and a solid finance position, UpNano GmbH, a commercial-stage technology company and leader in 2...